Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance
- Autores
- Lodillinsky, Catalina; Fuhrmann, Laetitia; Irondelle, Marie; Pylypenko, Olena; Li, Xiao Yan; Bonsang Kitzis, Hélène; Reyal, Fabien; Vacher, Sophie; Calmel, Claire; De Wever, Olivier; Bièche, Ivan; Lacombe, Marie Lise; Eijan, Ana Maria; Houdusse, Anne; Vincent Salomon, Anne; Weiss, Stephen J.; Chavrier, Philippe; Boissan, Mathieu
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Membrane Type 1 Matrix Metalloprotease (MT1-MMP) contributes to the invasive progression of breast cancers by degrading extracellular matrix tissues. Nucleoside diphosphate kinase, NME1/NM23-H1, has been identified as a metastasis suppressor; however, its contribution to local invasion in breast cancer is not known. Here, we report that NME1 is upregulated in ductal carcinoma in situ (DCIS) as compared to normal breast epithelial tissues. NME1 levels drop in microinvasive and invasive components of breast tumor cells relative to synchronous DCIS foci. We find a strong anticorrelation between NME1 and plasma membrane MT1-MMP levels in the invasive components of breast tumors, particularly in aggressive histological grade III and triple-negative breast cancers. Knockout of NME1 accelerates the invasive transition of breast tumors in the intraductal xenograft model. At the mechanistic level, we find that MT1-MMP, NME1 and dynamin-2, a GTPase known to require GTP production by NME1 for its membrane fission activity in the endocytic pathway, interact in clathrin-coated vesicles at the plasma membrane. Loss of NME1 function increases MT1- MMP surface levels by inhibiting endocytic clearance. As a consequence, the ECM degradation and invasive potentials of breast cancer cells are enhanced. This study identifies the down-modulation of NME1 as a potent driver of the in situ-to invasive transition during breast cancer progression.
Fil: Lodillinsky, Catalina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: Fuhrmann, Laetitia. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia
Fil: Irondelle, Marie. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia
Fil: Pylypenko, Olena. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia
Fil: Li, Xiao Yan. University of Michigan; Estados Unidos
Fil: Bonsang Kitzis, Hélène. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia. Institut National de la Santé et de la Recherche Médicale; Francia
Fil: Reyal, Fabien. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia. Institut National de la Santé et de la Recherche Médicale; Francia
Fil: Vacher, Sophie. Institute Curie; Francia
Fil: Calmel, Claire. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; Francia
Fil: De Wever, Olivier. University of Ghent; Bélgica
Fil: Bièche, Ivan. Institute Curie; Francia
Fil: Lacombe, Marie Lise. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; Francia
Fil: Eijan, Ana Maria. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: Houdusse, Anne. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia
Fil: Vincent Salomon, Anne. Institute Curie; Francia
Fil: Weiss, Stephen J.. University of Michigan; Estados Unidos
Fil: Chavrier, Philippe. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia
Fil: Boissan, Mathieu. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; Francia. Tenon Hospital; Francia - Materia
-
BREAST CANCER
MT1-MMP
NME1/NM23-H1
METATATIC GENE SUPRESSOR - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/156834
Ver los metadatos del registro completo
id |
CONICETDig_dc12d135ac4a94ca01ce7130041c873d |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/156834 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearanceLodillinsky, CatalinaFuhrmann, LaetitiaIrondelle, MariePylypenko, OlenaLi, Xiao YanBonsang Kitzis, HélèneReyal, FabienVacher, SophieCalmel, ClaireDe Wever, OlivierBièche, IvanLacombe, Marie LiseEijan, Ana MariaHoudusse, AnneVincent Salomon, AnneWeiss, Stephen J.Chavrier, PhilippeBoissan, MathieuBREAST CANCERMT1-MMPNME1/NM23-H1METATATIC GENE SUPRESSORhttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3Membrane Type 1 Matrix Metalloprotease (MT1-MMP) contributes to the invasive progression of breast cancers by degrading extracellular matrix tissues. Nucleoside diphosphate kinase, NME1/NM23-H1, has been identified as a metastasis suppressor; however, its contribution to local invasion in breast cancer is not known. Here, we report that NME1 is upregulated in ductal carcinoma in situ (DCIS) as compared to normal breast epithelial tissues. NME1 levels drop in microinvasive and invasive components of breast tumor cells relative to synchronous DCIS foci. We find a strong anticorrelation between NME1 and plasma membrane MT1-MMP levels in the invasive components of breast tumors, particularly in aggressive histological grade III and triple-negative breast cancers. Knockout of NME1 accelerates the invasive transition of breast tumors in the intraductal xenograft model. At the mechanistic level, we find that MT1-MMP, NME1 and dynamin-2, a GTPase known to require GTP production by NME1 for its membrane fission activity in the endocytic pathway, interact in clathrin-coated vesicles at the plasma membrane. Loss of NME1 function increases MT1- MMP surface levels by inhibiting endocytic clearance. As a consequence, the ECM degradation and invasive potentials of breast cancer cells are enhanced. This study identifies the down-modulation of NME1 as a potent driver of the in situ-to invasive transition during breast cancer progression.Fil: Lodillinsky, Catalina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Fuhrmann, Laetitia. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Irondelle, Marie. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Pylypenko, Olena. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Li, Xiao Yan. University of Michigan; Estados UnidosFil: Bonsang Kitzis, Hélène. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia. Institut National de la Santé et de la Recherche Médicale; FranciaFil: Reyal, Fabien. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia. Institut National de la Santé et de la Recherche Médicale; FranciaFil: Vacher, Sophie. Institute Curie; FranciaFil: Calmel, Claire. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; FranciaFil: De Wever, Olivier. University of Ghent; BélgicaFil: Bièche, Ivan. Institute Curie; FranciaFil: Lacombe, Marie Lise. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; FranciaFil: Eijan, Ana Maria. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Houdusse, Anne. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Vincent Salomon, Anne. Institute Curie; FranciaFil: Weiss, Stephen J.. University of Michigan; Estados UnidosFil: Chavrier, Philippe. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Boissan, Mathieu. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; Francia. Tenon Hospital; FranciaNature Publishing Group2021-06-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/156834Lodillinsky, Catalina; Fuhrmann, Laetitia; Irondelle, Marie; Pylypenko, Olena; Li, Xiao Yan; et al.; Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance; Nature Publishing Group; Oncogene; 40; 10-6-2021; 1-140950-92321476-5594CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/s41388-021-01826-1info:eu-repo/semantics/altIdentifier/doi/10.1038/s41388-021-01826-1info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:20:18Zoai:ri.conicet.gov.ar:11336/156834instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:20:18.846CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance |
title |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance |
spellingShingle |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance Lodillinsky, Catalina BREAST CANCER MT1-MMP NME1/NM23-H1 METATATIC GENE SUPRESSOR |
title_short |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance |
title_full |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance |
title_fullStr |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance |
title_full_unstemmed |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance |
title_sort |
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance |
dc.creator.none.fl_str_mv |
Lodillinsky, Catalina Fuhrmann, Laetitia Irondelle, Marie Pylypenko, Olena Li, Xiao Yan Bonsang Kitzis, Hélène Reyal, Fabien Vacher, Sophie Calmel, Claire De Wever, Olivier Bièche, Ivan Lacombe, Marie Lise Eijan, Ana Maria Houdusse, Anne Vincent Salomon, Anne Weiss, Stephen J. Chavrier, Philippe Boissan, Mathieu |
author |
Lodillinsky, Catalina |
author_facet |
Lodillinsky, Catalina Fuhrmann, Laetitia Irondelle, Marie Pylypenko, Olena Li, Xiao Yan Bonsang Kitzis, Hélène Reyal, Fabien Vacher, Sophie Calmel, Claire De Wever, Olivier Bièche, Ivan Lacombe, Marie Lise Eijan, Ana Maria Houdusse, Anne Vincent Salomon, Anne Weiss, Stephen J. Chavrier, Philippe Boissan, Mathieu |
author_role |
author |
author2 |
Fuhrmann, Laetitia Irondelle, Marie Pylypenko, Olena Li, Xiao Yan Bonsang Kitzis, Hélène Reyal, Fabien Vacher, Sophie Calmel, Claire De Wever, Olivier Bièche, Ivan Lacombe, Marie Lise Eijan, Ana Maria Houdusse, Anne Vincent Salomon, Anne Weiss, Stephen J. Chavrier, Philippe Boissan, Mathieu |
author2_role |
author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
BREAST CANCER MT1-MMP NME1/NM23-H1 METATATIC GENE SUPRESSOR |
topic |
BREAST CANCER MT1-MMP NME1/NM23-H1 METATATIC GENE SUPRESSOR |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.4 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Membrane Type 1 Matrix Metalloprotease (MT1-MMP) contributes to the invasive progression of breast cancers by degrading extracellular matrix tissues. Nucleoside diphosphate kinase, NME1/NM23-H1, has been identified as a metastasis suppressor; however, its contribution to local invasion in breast cancer is not known. Here, we report that NME1 is upregulated in ductal carcinoma in situ (DCIS) as compared to normal breast epithelial tissues. NME1 levels drop in microinvasive and invasive components of breast tumor cells relative to synchronous DCIS foci. We find a strong anticorrelation between NME1 and plasma membrane MT1-MMP levels in the invasive components of breast tumors, particularly in aggressive histological grade III and triple-negative breast cancers. Knockout of NME1 accelerates the invasive transition of breast tumors in the intraductal xenograft model. At the mechanistic level, we find that MT1-MMP, NME1 and dynamin-2, a GTPase known to require GTP production by NME1 for its membrane fission activity in the endocytic pathway, interact in clathrin-coated vesicles at the plasma membrane. Loss of NME1 function increases MT1- MMP surface levels by inhibiting endocytic clearance. As a consequence, the ECM degradation and invasive potentials of breast cancer cells are enhanced. This study identifies the down-modulation of NME1 as a potent driver of the in situ-to invasive transition during breast cancer progression. Fil: Lodillinsky, Catalina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina Fil: Fuhrmann, Laetitia. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia Fil: Irondelle, Marie. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia Fil: Pylypenko, Olena. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia Fil: Li, Xiao Yan. University of Michigan; Estados Unidos Fil: Bonsang Kitzis, Hélène. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia. Institut National de la Santé et de la Recherche Médicale; Francia Fil: Reyal, Fabien. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia. Institut National de la Santé et de la Recherche Médicale; Francia Fil: Vacher, Sophie. Institute Curie; Francia Fil: Calmel, Claire. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; Francia Fil: De Wever, Olivier. University of Ghent; Bélgica Fil: Bièche, Ivan. Institute Curie; Francia Fil: Lacombe, Marie Lise. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; Francia Fil: Eijan, Ana Maria. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina Fil: Houdusse, Anne. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia Fil: Vincent Salomon, Anne. Institute Curie; Francia Fil: Weiss, Stephen J.. University of Michigan; Estados Unidos Fil: Chavrier, Philippe. Institute Curie; Francia. Centre National de la Recherche Scientifique; Francia Fil: Boissan, Mathieu. Sorbonne University; Francia. Institut National de la Santé et de la Recherche Médicale; Francia. Tenon Hospital; Francia |
description |
Membrane Type 1 Matrix Metalloprotease (MT1-MMP) contributes to the invasive progression of breast cancers by degrading extracellular matrix tissues. Nucleoside diphosphate kinase, NME1/NM23-H1, has been identified as a metastasis suppressor; however, its contribution to local invasion in breast cancer is not known. Here, we report that NME1 is upregulated in ductal carcinoma in situ (DCIS) as compared to normal breast epithelial tissues. NME1 levels drop in microinvasive and invasive components of breast tumor cells relative to synchronous DCIS foci. We find a strong anticorrelation between NME1 and plasma membrane MT1-MMP levels in the invasive components of breast tumors, particularly in aggressive histological grade III and triple-negative breast cancers. Knockout of NME1 accelerates the invasive transition of breast tumors in the intraductal xenograft model. At the mechanistic level, we find that MT1-MMP, NME1 and dynamin-2, a GTPase known to require GTP production by NME1 for its membrane fission activity in the endocytic pathway, interact in clathrin-coated vesicles at the plasma membrane. Loss of NME1 function increases MT1- MMP surface levels by inhibiting endocytic clearance. As a consequence, the ECM degradation and invasive potentials of breast cancer cells are enhanced. This study identifies the down-modulation of NME1 as a potent driver of the in situ-to invasive transition during breast cancer progression. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06-10 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/156834 Lodillinsky, Catalina; Fuhrmann, Laetitia; Irondelle, Marie; Pylypenko, Olena; Li, Xiao Yan; et al.; Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance; Nature Publishing Group; Oncogene; 40; 10-6-2021; 1-14 0950-9232 1476-5594 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/156834 |
identifier_str_mv |
Lodillinsky, Catalina; Fuhrmann, Laetitia; Irondelle, Marie; Pylypenko, Olena; Li, Xiao Yan; et al.; Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance; Nature Publishing Group; Oncogene; 40; 10-6-2021; 1-14 0950-9232 1476-5594 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/s41388-021-01826-1 info:eu-repo/semantics/altIdentifier/doi/10.1038/s41388-021-01826-1 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Nature Publishing Group |
publisher.none.fl_str_mv |
Nature Publishing Group |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614182717095936 |
score |
13.070432 |